Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments and delivering a comprehensive medical cannabis care platform in Canada. Avicanna has an established scientific platform including R&D and clinical development that has led to the commercialization of more than thirty products across various market segments:
Medical Cannabis & Wellness Products (RHO Phyto™)
Pharmaceutical Preparations and Pipeline
MyMedi.ca Medical Cannabis Care
Aras founded Avicanna with the vision of establishing an international biopharmaceutical company with a strict focus on medical and pharmaceutical applications of naturally derived medicines including cannabinoids. His experience in...
Joining the Company in 2021 as Senior Vice President of Finance, Phillip took over as Chief Financial Officer in May 2022. He gained his experience at MNP LLP in the public company assurance group, where he worked with new and young companies,...